A forthcoming special issue of the Journal of Pharmaceutical Investigation will gather research on how particle engineering ...
A January 2027 special issue of the Journal of Pharmaceutical Investigation will spotlight how particle engineering and ...
Agrosaf Pharmaceuticals is expanding its B2B healthcare distribution model by connecting directly with pharmacy owners and healthcare retailers, combining a broad product portfolio with digital ...
Lifevision Healthcare, a Chandigarh-based pharmaceutical manufacturing company, is expanding its third-party manufacturing ...
Ahmedabad-based Nectar Life Care and Kashmik Formulations Private Limited have agreed to stop using seven names for ...
Under the plan's 2030 benchmarks, Vietnam targets meeting roughly 20% of domestic demand for drug-manufacturing raw materials ...
Newspoint on MSN
Massive relief for patients: Government caps cancer drug margins at 30%, slashing costs by up to 70%
In a landmark healthcare intervention, the government has capped the trade margin on all non-scheduled cancer-treating medications at 30 percent of the Maximum Retail Price (MRP). The decisive reform ...
According to MarketsandMarkets™, the Pharmaceutical Excipients Market is projected to reach USD 15.99 billion by 2031 from ...
Gelteq has early company-reported data on a gel for oral drug delivery and a commercial product. Clinical proof and repeat customers are the next test.
XORTX Therapeutics Inc. stocks have been trading up by 16.7 percent following highly positive biotech pipeline advancement ...
WELTRUZA ™ (olanzapine) for extended-release injectable suspension is the first and only once-monthly subcutaneous ...
XORTX Therapeutics Inc. ( XRTX ), a clinical-stage pharmaceutical company, outlined plans to submit a Clinical Trial Application (CTA) to Health Canada for XORLO (XRx-026), its investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results